Influence of glycation of plasma proteins in diabetes on the binding interaction with polyphenols
Wei Xu, Longsheng Chen, Rong Shao1
1School of Chemical and Biological Engineering, Yancheng Institute of Technology, 224051 Yancheng, China. sr@ycit.cn.
Abstract:
Diabetes mellitus is one of the most serious diseases in the world. The degree of glycated plasma proteins is increased in diabetics compared to non-diabetic subjects. This mini-review focuses on the influence of glycation of human serum albumin (HSA) in diabetes on the binding interaction with dietary polyphenols. The non-enzymatic glycation of HSA leads to a conformational change in HSA, which in turn influences the ligand binding properties. HSA glycation is believed to reduce the binding affinities for acidic drugs such as dietary polyphenols and phenolic acids.
More Related Videos
Related Concept Videos
Hyperglycemia
Dipeptidyl Peptidase 4 Inhibitors
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Diabetic Nephropathy
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Proteoglycans


